Literature DB >> 26410370

CIRCUS: a kiss of death for cardioprotection?

Gerd Heusch1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26410370     DOI: 10.1093/cvr/cvv225

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  9 in total

1.  Human Tissue-Engineered Model of Myocardial Ischemia-Reperfusion Injury.

Authors:  Timothy Chen; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part A       Date:  2018-11-20       Impact factor: 3.845

Review 2.  9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection.

Authors:  R M Bell; H E Bøtker; R D Carr; S M Davidson; J M Downey; D P Dutka; G Heusch; B Ibanez; R Macallister; C Stoppe; M Ovize; A Redington; J M Walker; D M Yellon
Journal:  Basic Res Cardiol       Date:  2016-05-10       Impact factor: 17.165

3.  Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy.

Authors:  Gen Suzuki; Rebeccah F Young; Merced M Leiker; Takayuki Suzuki
Journal:  Stem Cells Int       Date:  2016-09-22       Impact factor: 5.443

4.  Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning.

Authors:  Nilguen Gedik; Leonardo Maciel; Christiane Schulte; Andreas Skyschally; Gerd Heusch; Petra Kleinbongard
Journal:  Arch Med Sci       Date:  2016-08-16       Impact factor: 3.318

Review 5.  Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery.

Authors:  Derek J Hausenloy; Jose A Barrabes; Hans Erik Bøtker; Sean M Davidson; Fabio Di Lisa; James Downey; Thomas Engstrom; Péter Ferdinandy; Hector A Carbrera-Fuentes; Gerd Heusch; Borja Ibanez; Efstathios K Iliodromitis; Javier Inserte; Robert Jennings; Neena Kalia; Rajesh Kharbanda; Sandrine Lecour; Michael Marber; Tetsuji Miura; Michel Ovize; Miguel A Perez-Pinzon; Hans Michael Piper; Karin Przyklenk; Michael Rahbek Schmidt; Andrew Redington; Marisol Ruiz-Meana; Gemma Vilahur; Jakob Vinten-Johansen; Derek M Yellon; David Garcia-Dorado
Journal:  Basic Res Cardiol       Date:  2016-10-20       Impact factor: 17.165

6.  Modelling ischemia-reperfusion injury (IRI) in vitro using metabolically matured induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Alejandro Hidalgo; Nick Glass; Dmitry Ovchinnikov; Seung-Kwon Yang; Xinli Zhang; Stuart Mazzone; Chen Chen; Ernst Wolvetang; Justin Cooper-White
Journal:  APL Bioeng       Date:  2018-03-20

7.  Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside.

Authors:  Hector A Cabrera-Fuentes; Corina Alba-Alba; Julian Aragones; Jürgen Bernhagen; William A Boisvert; Hans E Bøtker; Gabriela Cesarman-Maus; Ingrid Fleming; David Garcia-Dorado; Sandrine Lecour; Elisa Liehn; Michael S Marber; Nephtali Marina; Manuel Mayr; Oscar Perez-Mendez; Tetsuji Miura; Marisol Ruiz-Meana; Eduardo M Salinas-Estefanon; Sang-Bing Ong; Hans J Schnittler; Jose T Sanchez-Vega; Adriana Sumoza-Toledo; Carl-Wilhelm Vogel; Dina Yarullina; Derek M Yellon; Klaus T Preissner; Derek J Hausenloy
Journal:  Basic Res Cardiol       Date:  2015-12-14       Impact factor: 17.165

8.  Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.

Authors:  Derek J Hausenloy; Hans Erik Botker; Thomas Engstrom; David Erlinge; Gerd Heusch; Borja Ibanez; Robert A Kloner; Michel Ovize; Derek M Yellon; David Garcia-Dorado
Journal:  Eur Heart J       Date:  2017-04-01       Impact factor: 29.983

Review 9.  Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction.

Authors:  Hans Erik Bøtker; Hector Alejandro Cabrera-Fuentes; Marisol Ruiz-Meana; Gerd Heusch; Michel Ovize
Journal:  J Cell Mol Med       Date:  2020-01-22       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.